JJ PHARMA CONSULT ApS: Financial statements 2014
CVR: 33257635
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -22,985 and a net result of DKK 920,163 compared with DKK 94,586 the year before. Equity in the 2014 report amounted to DKK 933,614. The solvency ratio was 98.5%.
- Gross Profit
- DKK -22,985
- Profit/Loss
- DKK 920,163
- Equity
- DKK 933,614
- Total Assets
- DKK 948,071
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -23 t. | 920 t. | 934 t. | - |
| 2013 | - | -9 t. | 95 t. | 183 t. | - |
| 2012 | - | -6 t. | 22 t. | 89 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
JJ PHARMA CONSULT ApS has published its annual report for 2013. Gross profit came to DKK -8,909, and the net result was DKK 94,586.
About JJ PHARMA CONSULT ApS
JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.